The induction of ubiquitination and consequent lysosomal degradation of EGFR, both in vitro and in vivo, is another molecular mechanism that has been proposed to explain the anti-proliferative effect of HTyr treatment in colon cancer [94]. Here, EGFR is linked to colonic neoplasm.